Lotte Chemical Corporation (KRX: 011170)

Lotte Chemical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	20,162,008	19,946,397	22,276,083	18,120,462	12,223,032	15,123,478
Other Revenue	0	-0	-0	-	-	-
Revenue	20,162,008	19,946,397	22,276,083	18,120,462	12,223,032	15,123,478
Revenue Growth (YoY)	-6.78%	-10.46%	22.93%	48.25%	-19.18%	-5.91%
Cost of Revenue	19,537,622	19,181,708	22,008,133	15,670,694	11,084,833	13,219,741
Gross Profit	624,386	764,688	267,950	2,449,768	1,138,199	1,903,736
Selling, General & Admin	951,927	929,643	864,705	776,157	650,039	659,554
Research & Development	132,830	120,369	102,444	92,453	80,029	84,575
Other Operating Expenses	11,835	15,594	10,168	9,618	8,996	15,821
Operating Expenses	1,155,547	1,123,963	1,030,871	914,127	781,127	798,236
Operating Income	-531,160	-359,274	-762,922	1,535,641	357,072	1,105,500
Interest Expense	-419,506	-378,888	-149,890	-85,171	-107,677	-113,222
Interest & Investment Income	206,164	205,828	75,196	31,583	54,996	103,434
Earnings From Equity Investments	91,335	54,741	-19,258	365,928	68,051	305,747
Currency Exchange Gain (Loss)	33,938	-14,820	-72,260	-22,065	-10,720	-11,563
Other Non Operating Income (Expenses)	10,660	20,422	638,648	75,823	-77,790	-3,041
EBT Excluding Unusual Items	-608,569	-471,991	-290,486	1,901,738	283,932	1,386,856
Impairment of Goodwill	-	-	-333,708	-	-	-
Gain (Loss) on Sale of Investments	-58,647	-57,218	-66,305	17,185	6,724	615.35
Gain (Loss) on Sale of Assets	17,859	19,213	5,277	-15,222	16,841	787.87
Asset Writedown	-116,162	-116,195	-113,264	-16,218	-60,751	-139,704
Pretax Income	-763,474	-452,271	-392,619	1,887,484	246,746	1,248,555
Income Tax Expense	-473,194	-413,028	-420,440	473,836	71,398	389,970
Earnings From Continuing Operations	-290,280	-39,243	27,820	1,413,648	175,348	858,584
Earnings From Discontinued Operations	-	-	-	-	-	-101,918
Net Income to Company	-290,280	-39,243	27,820	1,413,648	175,348	756,666
Minority Interest in Earnings	13,383	-10,800	33,773	-79,947	-16,879	-41,688
Net Income	-276,897	-50,043	61,594	1,333,701	158,469	714,978
Net Income to Common	-276,897	-50,043	61,594	1,333,701	158,469	714,978
Net Income Growth	-	-	-95.38%	741.62%	-77.84%	-54.73%
Shares Outstanding (Basic)	42	42	34	34	34	34
Shares Outstanding (Diluted)	42	42	34	34	34	34
Shares Change (YoY)	12.63%	22.11%	-0.28%	-	-	-
EPS (Basic)	-6545.26	-1198.96	1802.02	38911.30	4623.40	20859.79
EPS (Diluted)	-6545.26	-1198.96	1802.02	38911.30	4623.40	20859.79
EPS Growth	-	-	-95.37%	741.62%	-77.84%	-54.73%
Free Cash Flow	-2,267,467	-2,850,492	-2,760,068	712,887	508,476	385,633
Free Cash Flow Per Share	-53598.09	-68293.69	-80750.09	20798.78	14835.01	11251.00
Dividend Per Share	4500.000	3500.000	3500.000	8300.000	3600.000	6700.000
Dividend Growth	28.57%	0%	-57.83%	130.56%	-46.27%	-36.19%
Gross Margin	3.10%	3.83%	1.20%	13.52%	9.31%	12.59%
Operating Margin	-2.63%	-1.80%	-3.42%	8.47%	2.92%	7.31%
Profit Margin	-1.37%	-0.25%	0.28%	7.36%	1.30%	4.73%
Free Cash Flow Margin	-11.25%	-14.29%	-12.39%	3.93%	4.16%	2.55%
EBITDA	726,687	813,311	184,996	2,368,377	1,187,961	1,837,062
EBITDA Margin	3.60%	4.08%	0.83%	13.07%	9.72%	12.15%
D&A For EBITDA	1,257,847	1,172,586	947,917	832,736	830,889	731,562
EBIT	-531,160	-359,274	-762,922	1,535,641	357,072	1,105,500
EBIT Margin	-2.63%	-1.80%	-3.42%	8.47%	2.92%	7.31%
Effective Tax Rate	-	-	-	25.10%	28.94%	31.23%
Advertising Expenses	-	21,791	17,019	42,236	28,038	46,703

Source: S&P Capital IQ. Standard template. Financial Sources.